期刊文献+

小剂量替罗非班在高龄不稳定型心绞痛患者中的疗效及安全性观察

Observation on Safety and Efficacy of Low Dose Tirofiban in elderly patients with Unstable Angina
暂未订购
导出
摘要 目的:探讨小剂量替罗非班治疗70岁以上高龄不稳定型心绞痛患者的疗效及安全性。方法:86例高龄不稳定型心绞痛患者随机分为对照组与观察组。对照组应用常规抗凝、抗血小板治疗,观察组另加用半剂量的替罗非班,观察72 h后病情变化。结果:治疗72 h,观察组总有效率为97.67%,对照组总有效率为81.4%,差异有统计学意义(P<0.05)。结论:小剂量替罗非班治疗70岁以上不稳定型心绞痛患者安全有效,值得临床推广。 Objective To investigate the safety and effectiveness of low dose tirofiban in elderly patients with unstable angina.Methods The selected 86 cases of unstable angina were divided into the tirofiban group and the control group according to the treatment sequence.Both groups were routinely used the ordinary drug.While the tirofiban group was added low dose tirofiban for 48 hours.Comparisons of the reactions between the two groups after 72h treatments.Results At 72 hours the total effective rate of the tirofiban group and the control group were 97.67% and 81.4% respectively(P0.05).Conclusion In the treatment of elderly patients with unstable angina,low dose Tirofiban was relatively safe and effective.
出处 《吉林医学》 CAS 2011年第9期1680-1681,共2页 Jilin Medical Journal
关键词 小剂量 替罗非班 高龄 不稳定型心绞痛 Low dose Tirofiban Elderly Unstable angina
  • 相关文献

参考文献4

二级参考文献12

  • 1Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation, 2002,105 : 656-662.
  • 2Brener SJ, Barr LA, Burchenal JE, et al. Randomized, placebo-controlled trial of platelet glycoprotein Ⅱ b/Ⅲ a blockade with primary PTCA Organization and Randomized Trial ( RAPPORT ). Circulation, 1998,98 : 734-741.
  • 3Montalescot G, Barragan P, Wittenberg O, et al. For the ADMIRAL Investigators. Platelet glycoprotein Ⅱ b/Ⅲ a inhibition with coronary stenting for acute myocardial infarction. N Eng J Med, 2001, 344:1895-1903.
  • 4Stone GW, Grines CL, Cox DA, et al. Comparision of angioplasty with stenting, with or without abciximab, in acuete myocardial infarction. N Eng J Med, 2002, 346 : 957-966.
  • 5Neumann FJ, Blasini R, Schmitt C, et al. Effect of glycoprotein Ⅱ b/Ⅲ a receptor blockade on recovery flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infction. Circulation, 1998, 98 : 2695-2701.
  • 6Petronioa AS, Rovai D, Musumeci G, et al. Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty. Euro Heart Journal, 2003, 24: 67-76.
  • 7The RESTORE Investigators. Effects of platelet glycoprotein Ⅱ b/Ⅲ a blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation, 1997, 96: 1445-1453.
  • 8Lincoff AM. Trial of platelet glycoprotein Ⅱ b/Ⅲ a receptor antagonists during percutaneous coronary revascularization. Am J Cardiol, 1998, 82:36-42.
  • 9Danzi GB, Sesana M, Capuano C, et al. Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function. Am J Cardiol, 2004, 94:35-39.
  • 10Gibson CM, Christopher PC, William LD, et al. TIMI frame count : A quantitative method of assessing coronary artery flow. Circulation, 1996,93 : 879-888.

共引文献2787

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部